• Home
  • Stock
  • Bal Pharma Fundamental Analysis
  • Bal Pharma Fundamental Analysis

Bal Pharma fundamental analysis

BALPHARMA

HealthcareSmall

82.88

1.02 (1.25%)
Last updated on 10 Nov, 2025 | 10:49 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Bal Pharma Fundamentals

P/E Ratio

18.22

P/B Ratio

1.68

Div. Yield

1.47

Sector P/E

36.99

Sector P/B

3.63

Sec. Div. Yield

0.56

  • Bal Pharma Fundamentals is currently trading with a P/E Ratio of 18.22, compared to the sector average of 36.99. Its P/B Ratio stands at 1.68, while the sector’s is 3.63. In terms of returns, the stock offers a Dividend Yield of 1.47%, which is than the sector’s 0.56%.

Bal Pharma Score Card

  • Price

    Attractive

  • Growth

    Average

  • Quality

    Poor

  • Management

    Poor

  • On its scorecard, Bal Pharma reflects: Price – Attractive, Growth – Average, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.